---
created: 2025-04-13
updated: 2025-04-13T10:53
id: x:lL^Rx21.
specialty: pharmaco
specialty_id: 349
tags:
  - source/ak-original-decks::step-1::zanki-pharmacology
  - "source/ak-step1-v11:": 
  - theme/firstaid::11-musculoskeletal-skin-connective-tissue::04-pharm::09-gout-drugs
  - "source/ak-step1-v11:": 
  - theme/firstaid::11-musculoskeletal-skin-connective-tissue::04-pharm::09-gout-drugs::chronic::probenecid
  - "source/ak-step1-v11:": 
  - source/ome-banner::basic-science::10-musculoskeletal
  - "source/ak-step1-v11:": 
  - theme/physeo::09-pharm::09-musculoskeletal::08-acute-and-chronic-gout-treatment
  - "source/ak-step1-v11:": 
  - theme/pixorize::03-pharm::12-msk::probenecid
  - "source/ak-step1-v11:": 
  - theme/sketchypharm::03-blood-&-inflammation::03-anti-inflammatory::02-gout-drugs::zanki-extra
  - "source/ak-step1-v11:": 
  - theme/uworld::1000-9999::6000-6999::6635
  - source/ak-step1-v11::^other::^expn
  - source/ak-step1-v11::^other::^highyield::3-highyield-temporary"
type: flashcard
---

# Question
Patients taking drugs that are excreted via the renal tubular basolateral OAT channels (ex Penicillin, Cephalosporins, Methotrexate) should be monitored carefully while taking **Probenecid**

---

# Answer
- This channels transports Uric Acid from the blood into the renal proximal tubule cell  - Thus probenecid use can lead to impaired excretion (and thus increased toxicity) of these drugs